官方服务：
资源简介：
PD-L1 expression of U87MG and LN229 cells.
应用场景：
创建时间：
2022-09-01
相关数据集
Supplementary Tables – Indirect comparison of pembrolizumab monotherapy versus nivolumab+ipilimumab in first-line metastatic lung cancer
Table S1 Base case scenario of overall survival and progression-free survival in patients with PD-L1 TPS≥1% before matching Table S2 Landmark analysis of overall su
DataCite Commons2022-05-03 更新70
Expressions of PD-L1 on dog tumor cell lines.
The expression of PD-L1 was evaluated by flow cytometric analysis using anti-PD-L1 mAb 4G12-C1. -; 60% positive.*Cells were incubated with recombinant canine IFN-γ (100 ng/ml) for 24 h before the anal
Figshare2015-12-02 更新40
High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer
Immune checkpoint-inhibitors targeting the PD-1/PD-L1 system are FDA approved in microsatellite instable (MSI) or mismatch repair deficient (dMMR) colorectal cancer (CRC). PD-L1 expression is tightly
NIAID Data Ecosystem40
Supplementary Table S12 from Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression
The most up- or downregulated gene sets in tumor cells between ID_PDL1H and ID_PDL1L
Figshare2024-12-03 更新40
PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
Background Tumor cells express programmed death ligand 1 (PD-L1) and is a key immune evasion mechanism. PD-L1 expression in multiple breast cancer cell lines was evaluated to identify intrinsic differ
NIAID Data Ecosystem40
